Loading quotes...

Forecast

There is no analyst data available for this company.


  • Mutares pushes ahead with portfolio cleanup and agrees sale of Natura

    Mutares has agreed the terms for the sale of drugstore chain Natura with Polish retail group Specjał. Natura operates more than 190 stores and has been comprehensively restructured since its 2024 takeover; the purchase price was not disclosed. The final contract is expected to be signed in the fourth quarter and the transaction completed, if possible, by year‑end. The share rose by more than four percent intraday after the news, but a sustained price boost depends on further exits such as Magirus, Efacec or NGS. » More on finanzen.net


  • Mutares signs sale of drugstore chain Natura

    Mutares has signed an agreement to divest the Polish drugstore chain Natura and aims to complete the transaction this quarter. The deal is part of its portfolio strategy to reduce exposure to the retail segment. Financial details were not disclosed; the stock rose to its highest level since mid-September. » More on finanzen.net


  • Mutares hits September high after agreement to sell Natura

    Mutares’s share rose to €26.05, reaching its highest level since mid-September. The company has signed an agreement to sell the Polish drugstore chain Natura, with completion planned for this quarter. The disposal is part of a portfolio strategy to reduce retail exposure; financial details were not disclosed. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Mutares has already paid €2.00 in dividends. The last payout was in July.

Financials

In the last quarter, Mutares had revenue of €3.38B and net profit of €104.6M
(EUR) June 2026
YoY
Revenue 3.38B -
Gross profit 217M -
Net profit 104.6M -
EBITDA -11.5M -

Fundamentals

Metric Value
Market capitalization
€730.11M
Number of shares
25.62M
52-week high/low
€35.10 - €23.25
Dividend yield
7.07%
Dividends TTM
€2.00
Beta
0.62
P/E ratio
5.36
PEG ratio
0.05
P/B ratio
0.83
P/S ratio
0.14

Company profile

Mutares SE & Co. KGaA is a private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, and re-funding. It also considers co-investments also. The firm typically acquires small and medium-sized companies. The firm invests its personal capital. It also focuses on platform and add-on acquisitions. The firm makes investments in automotive, wood and paper, construction and infrastructure, engineering, consumer good, Technology, commercial repair services, automobiles and components, healthcare equipment and services, materials including containers and packaging. The firm primarily invests in companies with established market positions and whose focus of activity is in Europe. It considers acquiring companies that have annual sales volume of more than €50 million ($55.31 million) and revenues between €50 million ($55.31 million) and €500 million ($538.71 million) with an EBITDA up to €5 million ($5.38 million). It prefers to acquire a controlling and majority stake in its portfolio companies. It typically makes long term investments with a holding period between three and five years. Mutares SE & Co. KGaA was founded in February, 2008 and is based in Munich, Germany, with additional offices in Europe.

Name
Mutares
CEO
Robin Laik
Headquarters Munich, bv
Germany
Website
Sector
Financials
Industry
Financial Services
IPO
05/07/2010
Employees 35,000

Ticker symbols

Exchange Symbol
XETRA
MUX.DE
Frankfurt
MUX.F
Düsseldorf
MUX.DU
Hamburg
MUX.HM
London
0UTK.L
München
MUX.MU
🍪

Parqet  uses cookies. Learn more